Menlo Park, CA – According to filings with the U.S. Securities and Exchange Commission, Hello Heart is raising $44,952,846.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Maayan Cohen played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Hello Heart
Hello Heart is the only digital therapeutics company to focus exclusively on heart disease, the leading cause of death worldwide. Through a connected mobile device that uses AI, behavioral science, and personalized digital coaching to drive lifestyle changes, Hello Heart empowers people to reduce blood pressure and predicts serious heart issues before they occur. Validated in peer-reviewed studies, Hello Heart is easy to use and works alongside an employers benefits ecosystem. Dozens of Fortune 500 employers are realizing immediate and sustained results for member engagement, clinical outcomes, and reduced cost of unnecessary cardiac procedures. Founded in 2013, Hello Heart is a member of the American Heart Associations Innovator Network, and is part of the CVS Point Solutions Management Program.

To learn more about Hello Heart, visit http://www.helloheart.com/

Contact:
Maayan Cohen, Chief Executive Officer
800-767-3471
maayan@helloheart.com
https://www.linkedin.com/in/cohenmaayan/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved